-
Cy5.5 NHS Ester for Mapping OA Nanogene Delivery
2026-09-20
Cy5.5 NHS ester (non-sulfonated) offers a near-infrared strategy for tracking amine-bearing delivery components in aged osteoarthritis models. This article connects covalent labeling chemistry with spatial assay design for evaluating hydrogel retention, nanoparticle transport, and translational imaging limits.
-
CD36 Lipid Sensing Drives Immune Escape in AML
2026-09-19
Guo and colleagues identify a CD36-dependent, non-canonical lipid-sensing program that enables AML cells to suppress T-cell activity and resist decitabine therapy. The study separates this immune function from lipid oxidation and supports statin-mediated lipid restriction as a strategy for improving hypomethylating-agent efficacy.
-
MK-1775 Workflow for Checkpoint Studies
2026-09-18
Use MK-1775 to interrogate Wee1-dependent G2 control, distinguish growth arrest from true cell killing, and test chemotherapy sensitization in p53-deficient models. This workflow combines phospho-CDC2 readouts, time-resolved viability measurements, and practical troubleshooting for more interpretable cancer research data.
-
EZ Cap™ Human PTEN mRNA (ψUTP) Workflow
2026-09-18
Use EZ Cap™ Human PTEN mRNA (ψUTP) to build controlled PTEN-expression experiments in mammalian cells, from pathway assays to nanoparticle-enabled cancer models. Its Cap 1 structure, pseudouridine modification, and poly(A) tail support efficient translation while helping researchers investigate PI3K/Akt signaling and therapeutic resistance.
-
Pexmetinib (ARRY-614): State-Aware Cytokine Research
2026-09-17
A translational perspective on Pexmetinib (ARRY-614) as a dual p38 MAPK and Tie2 inhibitor, integrating cytokine assay design, conformational kinase biology, hematologic research, and practical workflow guidance.
-
Sex Differences in Angiotensin II Hypertension
2026-09-17
Xue, Pamidimukkala, and Hay used telemetry in conscious mice to show that chronic angiotensin II produces a substantially larger blood-pressure increase in males than females. Gonadectomy, baroreflex testing, and ganglionic blockade further linked this divergence to sex-dependent hormonal and sympathetic regulation rather than baseline blood pressure alone.
-
Zosuquidar: A Decision Framework for P-gp Assays
2026-09-16
Zosuquidar (LY335979) is a selective P-glycoprotein modulator for dissecting efflux-driven drug resistance. This guide connects cancer sensitization assays with disease-state pharmacokinetic insights while clarifying experimental boundaries and controls.
-
In Vitro Drug Response Metrics in Cancer Research
2026-09-16
Hannah R. Schwartz’s 2022 dissertation shows that relative viability and fractional viability are complementary, not interchangeable, measures of anticancer drug response. Its central practical contribution is a framework for separating proliferative inhibition from cell killing, improving interpretation of checkpoint-targeted and combination-treatment experiments.
-
Electroporation for CRISPR/Cas9 Editing in Mouse Zygotes
2026-09-15
Hashimoto and Takemoto developed an electroporation workflow that delivers CRISPR/Cas9 RNAs into mouse zygotes without removing the zona pellucida. By optimizing pulse strength and repetition, the study established a scalable alternative to microinjection for knockout and ssODN-mediated knock-in experiments.
-
MYC2–LBD40/42 Control of Tomato Gray Mold Defense
2026-09-15
This study identifies a MYC2–LBD40/42–CRL3BPM4 module that fine-tunes tomato resistance to Botrytis cinerea by balancing immune activation with growth-related costs. Its central advance is the demonstration that LBD repressors act as reversible brakes: SlMYC2 induces them, while SlBPM4-dependent degradation releases defense activity.
-
Fluorescein TSA Fluorescence System Kit in Spatial Biology
2026-09-14
Spatial proteomics is moving toward cell-type resolution, but translational teams still need practical ways to validate low-abundance targets in intact tissue. This thought-leadership article explains how tyramide signal amplification complements proximity proteomics, outlines validation and workflow strategy, and positions the Fluorescein TSA Fluorescence System Kit as a targeted bridge between discovery-scale profiling and spatially resolved biological interpretation.
-
Vitamin K2, NRF2/FSP1, and Osteoblast Ferroptosis
2026-09-14
Zhang et al. report that vitamin K2 partially protects against glucocorticoid-induced osteoporosis by restoring osteoblast activity and limiting ferroptosis through the NRF2/FSP1 axis. The study connects mitochondrial dysfunction and lipid peroxidation with impaired osteogenic differentiation, providing a mechanistic framework for evaluating redox-directed interventions in bone loss.
-
NMDAR–Cav2.1 Control of PV Interneuron Maturation
2026-09-13
Singh and colleagues show that developmental NMDAR signaling in cortical parvalbumin interneurons is required for maturation of Cav2.1-dependent GABA release, rather than merely for maintaining excitability or calcium availability. Their genetic, electrophysiological, and pharmacological experiments provide a mechanistic framework for understanding how early NMDAR hypofunction may disrupt excitation–inhibition balance relevant to schizophrenia.
-
Tigecycline Workflows for Resistant Bacteria
2026-09-12
Tigecycline is a glycylcycline antibiotic suited to reproducible susceptibility, resistance-mechanism, and infection-model workflows. This guide connects ribosomal inhibition with plasmid surveillance in carbapenem-resistant Enterobacter cloacae, while providing practical preparation, assay, and troubleshooting guidance.
-
Deferoxamine mesylate in Iron and Hypoxia Assays
2026-09-11
Deferoxamine mesylate gives researchers a controllable way to reduce labile iron, probe oxidative stress, and model hypoxia-linked signaling. Its strongest value is as a mechanistic control across ferroptosis, HIF-1α stabilization, tumor biology, and wound-healing workflows rather than as a one-size-fits-all treatment.